McDermott + Bull has successfully placed Darrell Gene as the Senior Director of Technical Operations and Finance for Kite Pharma. Darrell will support Kite Pharma’s commercial and clinical operations across the globe including sites and direct reports in Southern California, Maryland, and the Netherlands.
Darrell has been in operational finance roles for over two decades with the majority of his time spent in the biotech and pharmaceutical industries. He has successfully been able to turn around multiple organizations through process improvements and strategic efficiencies.
Kite Pharma, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st-century medicine: curing cancer. This mission is at the heart of everything they do, from early research to product development. They are a company engaged in the development of innovative cancer immunotherapies with a goal of providing a rapid, long-term durable response and eliminating the burden of chronic care.
This executive search was completed by McDermott + Bull Managing Director + Co-founder Chris Bull, Managing Director Ken Dropiewski, and Executive Recruiter Quyen Doan.